Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Apoptosis and survival Anti-apoptotic TNFs/NF-kB/IAP pathway


Log In to Post A Comment

Apoptosis and survival Anti-apoptotic TNFs/NF-kB/IAP pathway

Anti-apoptotic TNFs/NF-kB/IAP pathway

Members of the tumour necrosis factor ligand family (TNFs) may induce both apoptoticand anti-apoptotic pathways. TNFs transduces cellular responses through activation ofdifferent TNF-receptors (TNFRs).

One important mechanism of cell survival is activation of transcription of differentanti-apoptotic proteins by TNFs via nuclear factors of the kappa light polypeptide inB-cells ( NF-kB ) signaling cascade [1]. Some TNFs/TNFRs activateexpression of anti-apoptotic members of the inhibitor of apoptosis protein (IAP) family.For example, expression of baculoviral IAP repeat-containing 2 ( c-IAP1 ),baculoviral IAP repeat-containing 3 ( c-IAP2 ), baculoviral IAP repeat-containing4 ( XIAP1 ) and/or baculoviral IAP repeat-containing 5 ( Survivin ) may bestimulated by:

. tumor necrosis factor, member 2 ( TNF-alpha )/ tumor necrosisfactor receptor superfamily, member 1A ( TNF-R1 ) and TNF-alpha/ tumornecrosis factor receptor superfamily, member 1B ( TNF-R2 ) [2],[3];

. tumor necrosis factor (ligand) superfamily, member 15 ( TL1A )/tumor necrosis factor receptor superfamily, member 25 ( DR3 ) [4];

. tumor necrosis factor (ligand) superfamily, member 8 ( CD30L )/tumor necrosis factor receptor superfamily, member 8 ( CD30 ) [5],[6];

. tumor necrosis factor (ligand) superfamily, member 13 ( APRIL )/tumor necrosis factor receptor superfamily, member 13B ( TACI ) and/orAPRIL/ tumor necrosis factor receptor superfamily, member 17 ( BCMA )[7].

TNFRs transduce cellular responses through activation of different TNFR -associatedfactors (TRAFs). These are TRAF2 and TRAF5. TRAF3 serves as anegative regulator of the NF-kappaB pathway for many receptors TNFRs [8].

Further, the activation and nuclear translocation of NF-kB proteins can occurafter the ligation of selected cell-surface TNFRs.

TRAF2 activates the inhibitor of kappa light polypeptide gene enhancer inB-cells, kinases alpha and beta ( IKK ), directly or via NIK kinase [2]. IKK subsequently phosphorylates NF-kB inhibitor ( I-kB ).Phosphorylation of I-kB leads to its ubiquitination and degradation within the 26Sproteasome. Degradation of I-kB liberates different NF-kB transcriptionfactors, enablng its rapid translocation from the cytoplasm into the nucleus where ittriggers transcription of the target genes [1].

The signal from TNF-R1 may be mediated by TNFR1-associated death domainprotein ( TRADD )/ receptor TNFR-interacting serine-threonine kinase 1 (RIPK1 ) pathway [9].

In addition, TNF-R1/ TNF-R2 signal may be mediated by NIK/IKK/ v-rel reticuloendotheliosis viral oncogene homolog A ( RelA ) [3].

Then, different NF-kB transfactors (including RelA ) activatetranscription of anti-apoptotic members of the IAP family ( c-IAP1, c-IAP2, XIAP and Survivin ), which inhibit various pro-apoptotic proteins [10].